Frequency, Clinical Features, and Imaging Comparisons of Seropositive versus Seronegative Autoimmune Encephalitis in a Tertiary Care Setting
Annals of Indian Academy of Neurology · 2025-03 · 28 (2) · 196-204
DOI: 10.4103/aian.aian_718_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Indian Academy of Neurology, online erschienen am 03.03.2025. Verfasst von Bhavani Madduluri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background and Objectives: Seronegative autoimmune encephalitis (SNAIE) is an enigmatic entity which lacks detectable autoantibodies, leading to a diagnostic delay. Our objective was to study the frequency of SNAIE and compare the clinical, electrophysiological, and imaging characteristics of patients with SNAIE to those in patients with seropositive autoimmune encephalitis (SPAIE).
Methods
This ambispective observational study was undertaken at a tertiary care center in South India for 7 years. The demographic data, clinical features, cerebrospinal fluid (CSF) analysis findings, electroencephalogram (EEG), and 3 T magnetic resonance imaging (MRI), and 18F fluoro-2-deoxy-d-glucose positron emission tomography computerized tomography (18F FDG PET–CT) findings were compared.
Results
Of the 64 subjects enrolled, SNAIE frequency was 62.5%, with a notable 3:1 male-to-female ratio. Seizure was the predominant clinical presentation in SNAIE compared to SPAIE (50% vs. 20%, P value 0.02). Refractory seizures (45% vs. 4.5%) and status epilepticus (37.5% vs. 0%) were more common in SNAIE ( P value 0.001), whereas involuntary movements and faciobrachial dystonic seizures were common in SPAIE (66% vs. 16%, P value 0.04). CSF pleocytosis was frequently seen in SPAIE (50% vs. 17%, P value 0.006). EEG findings in SNAIE included increased epileptiform discharges and built-up rhythms. FDG PET abnormalities were observed in both groups (91% SPAIE, 97% SNAIE), but the seropositive group exhibited more temporal lobe involvement (58% vs. 30%, P = 0.036) and SNAIE had more diffuse involvement.
Conclusions
SNAIE exhibited male predominance, primarily presenting with isolated seizure as the initial presentation. EEG and FDG PET findings distinguished the two groups, emphasizing the importance of these modalities as biomarkers in the early detection and management of SNAIE.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
- Department of Nuclear Medicine, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
- Department of Medicine, All India Institute of Medical Sciences, Hyderabad, Telangana, India.
Zitieren
APA
Madduluri, B., Jabeen, S. A., Shaik, R. S., Yareeda, S., Turaga, S., Srivastava, M. K., & Neeradi, C. (2025). Frequency, Clinical Features, and Imaging Comparisons of Seropositive versus Seronegative Autoimmune Encephalitis in a Tertiary Care Setting. Annals of Indian Academy of Neurology, 28(2), 196-204. https://doi.org/10.4103/aian.aian_718_24
Vancouver
Madduluri B, Jabeen SA, Shaik RS, Yareeda S, Turaga S, Srivastava MK, et al. Frequency, Clinical Features, and Imaging Comparisons of Seropositive versus Seronegative Autoimmune Encephalitis in a Tertiary Care Setting. Annals of Indian Academy of Neurology. 2025;28(2):196-204. doi:10.4103/aian.aian_718_24
BibTeX
@article{Madduluri2025,
author = {Madduluri, Bhavani and Jabeen, Shaik A and Shaik, Reshma S and Yareeda, Sireesha and Turaga, Suryaprabha and Srivastava, Madhur K and Neeradi, Charan},
title = {Frequency, Clinical Features, and Imaging Comparisons of Seropositive versus Seronegative Autoimmune Encephalitis in a Tertiary Care Setting},
journal = {Annals of Indian Academy of Neurology},
year = {2025},
volume = {28},
number = {2},
pages = {196--204},
doi = {10.4103/aian.aian_718_24}
}
EUVIMED